Insights

Cutting-Edge Cell Programming bit.bio utilizes opti-ox precision cell programming technology to efficiently create human cell types, offering novel solutions for research and drug discovery teams seeking consistent and scalable human cells.

Recent Product Launches The recent launch of ioTracker Cells range, including GFP ioMicroglia, showcases bit.bio's continuous innovation and product expansion, presenting opportunities for organizations aiming to enhance their cell-based research capabilities.

Strategic Financing Round Having secured a $30 million financing round led by M&G Investments, bit.bio demonstrates financial stability and growth potential, making it a promising partner for investors or collaborators looking to engage with a leader in cell programming technology.

Established Presence in Key Events By actively participating in renowned events like the Society for Laboratory Automation and Screening (SLAS) conference, bit.bio enhances brand visibility and networking opportunities, attracting potential clients interested in cutting-edge cell technologies.

Top Talent Acquisition With the recruitment of skilled professionals like Obloj, who brings extensive financial expertise to the team, bit.bio strengthens its strategic capabilities, signaling its readiness for strategic partnerships with organizations in the health, life sciences, and technology sectors.

bit.bio Tech Stack

bit.bio uses 8 technology products and services including Canva, WordPress, HubSpot Cookie Policy Banner, and more. Explore bit.bio's tech stack below.

  • Canva
    Audio, Video, Graphics
  • WordPress
    Content Management System
  • HubSpot Cookie Policy Banner
    Cookie Compliance
  • Envoy
    Load Balancers
  • Microsoft
    Miscellaneous
  • LinkedIn
    Online Community Software
  • Hadoop
    Programming Languages
  • LinkedIn Sales Navigator
    Sales Enablement

Media & News

bit.bio's Email Address Formats

bit.bio uses at least 1 format(s):
bit.bio Email FormatsExamplePercentage
First.Last@bit.bioJohn.Doe@bit.bio
62%
First@bit.bioJohn@bit.bio
29%
Last@bit.bioDoe@bit.bio
5%
FLast@bit.bioJDoe@bit.bio
4%

Frequently Asked Questions

Where is bit.bio's headquarters located?

Minus sign iconPlus sign icon
bit.bio's main headquarters is located at The Dorothy Hodgkin Building Babraham Research Campus Cambridge, Cambridgeshire CB22 3FH GB. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is bit.bio's official website and social media links?

Minus sign iconPlus sign icon
bit.bio's official website is bit.bio and has social profiles on LinkedIn.

How much revenue does bit.bio generate?

Minus sign iconPlus sign icon
As of March 2025, bit.bio's annual revenue reached $35M.

What is bit.bio's SIC code NAICS code?

Minus sign iconPlus sign icon
bit.bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does bit.bio have currently?

Minus sign iconPlus sign icon
As of March 2025, bit.bio has approximately 192 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Financial Officer: P. O.Chief Scientific Officer (svp): E. M.Vice President Operations: O. G.. Explore bit.bio's employee directory with LeadIQ.

What industry does bit.bio belong to?

Minus sign iconPlus sign icon
bit.bio operates in the Biotechnology Research industry.

What technology does bit.bio use?

Minus sign iconPlus sign icon
bit.bio's tech stack includes CanvaWordPressHubSpot Cookie Policy BannerEnvoyMicrosoftLinkedInHadoopLinkedIn Sales Navigator.

What is bit.bio's email format?

Minus sign iconPlus sign icon
bit.bio's email format typically follows the pattern of . Find more bit.bio email formats with LeadIQ.

How much funding has bit.bio raised to date?

Minus sign iconPlus sign icon
As of March 2025, bit.bio has raised $30M in funding. The last funding round occurred on Dec 16, 2024 for $30M.

When was bit.bio founded?

Minus sign iconPlus sign icon
bit.bio was founded in 2016.
bit.bio

bit.bio

Biotechnology ResearchCambridgeshire, United Kingdom51-200 Employees

bit.bio is an award-winning human synthetic biology company - our mission: coding cells for novel cures. 

We have developed an end-to-end platform for the creation of any human cell type. With our cutting-edge and patent-protected opti-ox precision cell programming technology, we can deterministically program human iPSCs into a chosen cell identity with unprecedented biological consistency at an industrial scale, and approximately 10 times faster than conventional methods. Our platform has the potential to unlock a new generation of medicines.

Our io Cells research products provide scientists access to highly characterised, consistent, scalable human cells that enable research and drug discovery teams to accelerate their experimental timelines and reduce experimental variability, providing an important alternative to traditional workflows. We are also leveraging our platform to build a pipeline of txCells for cell therapies.

To achieve our goals, we have assembled a team of pioneers in stem cell biology, cell programming, mathematical modelling and cell therapy. We are empirical, highly ambitious and driven by a shared vision.

Collaboration is at the heart of bit.bio. Join us on our journey. 

For more information on bit.bio’s trademarks, visit www.bit.bio/trademarks

Section iconCompany Overview

Headquarters
The Dorothy Hodgkin Building Babraham Research Campus Cambridge, Cambridgeshire CB22 3FH GB
Website
bit.bio
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $30M

    bit.bio has raised a total of $30M of funding over 5 rounds. Their latest funding round was raised on Dec 16, 2024 in the amount of $30M.

  • $10M$50M

    bit.bio's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $30M

    bit.bio has raised a total of $30M of funding over 5 rounds. Their latest funding round was raised on Dec 16, 2024 in the amount of $30M.

  • $10M$50M

    bit.bio's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.